More COVID-19 vaccines in the pipeline as US effort ramps up A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the... AP NEWS

A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak.

White House testing czar: UK coronavirus variant 'likely' in US Assistant Health and Human Services Secretary Adm. John Bowden TheHill

Assistant Health and Human Services Secretary Adm. Brett Giroir said Monday that a new, faster-spreading strain of coronavirus first found in the United Kingdom is "likely" already present in the U.S., though he cautioned that officials have no evidence of its presence yet.

The Latest: S. Korea confirms first COVID-19 variant cases SEOUL, South Korea — South Korea has confirmed its first cases of a more contagious variant of COVID-19 that was first identified in the United Kingdom. The Korea Disease Control and... AP NEWS

SEOUL, South Korea — South Korea has confirmed its first cases of a more contagious variant of COVID-19 that was first identified in the United Kingdom.

PALM BEACH, Fla./WASHINGTON (Reuters) - U.S. President Donald Trump on Sunday signed into law a $2.3 trillion pandemic aid and spending package, officials said, restoring unemployment benefits to millions of Americans and averting a partial federal government shutdown.

Trump, who leaves office on Jan. 20 after losing November’s election, backed down from his threat to block the bill, which was approved Congress last week, after he came under intense pressure from lawmakers on both sides.

The Republican president, who golfed on Sunday and remained out of public view even as the potential government shutdown loomed, had demanded that Congress change the bill to increase the size of stimulus checks for struggling Americans to $2,000 from $600.

It was not immediately clear why Trump changed his mind as his resistance to the massive legislative package promised a chaotic final stretch of his presidency.

AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19 Following criticism over initial trial, pharma giant's CEO believes general efficacy will be equal to Pfizer-BioNTech, Moderna; says data will be published 'at some point' timesofisrael

LONDON — The COVID-19 vaccine developed by the British drug group AstraZeneca and the University of Oxford has achieved a “winning formula” for efficacy, the company’s chief executive said on Sunday.